Working… Menu

Improving Prematurity-Related Respiratory Outcomes at Vanderbilt (IMPROV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01460576
Recruitment Status : Completed
First Posted : October 27, 2011
Last Update Posted : May 5, 2017
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Paul Moore, Vanderbilt University Medical Center

Brief Summary:
The goal of IMPROV is to identify molecular mechanisms that contribute to lung injury and long-term breathing problems in preterm infants by investigating two interrelated biochemical pathways: the urea cycle-nitric oxide pathway and the glutathione pathway. The investigators hypothesize that prematurity-related limitations in the function of these important biochemical pathways contribute to respiratory disease risk over the first year of life.

Condition or disease
Preterm Birth Bronchopulmonary Dysplasia Chronic Lung Disease of Prematurity

Detailed Description:
The primary goal of the IMPROV/PROP study is to identify biomarkers (biochemical, physiological and genetic) and clinical variables that are associated with and thus potentially predictive of pulmonary status in preterm infants at 1 year corrected age. IMPROV will test the hypothesis that biochemical immaturity and functional genetic variation in the urea cycle-nitric oxide (UC-NO) and glutathione (GSH) pathways influence the development and severity of bronchopulmonary dysplasia (BPD), a form of chronic lung disease that affects more than 10,000 premature infants each year in the US. IMPROV will also test the hypothesis that the duration and degree of NO insufficiency and free radical excess predicts BPD severity and correlates with persistence of lung problems after NICU discharge. Our hypothesis implicates (a) an immature liver and gastrointestinal ability to make citrulline and GSH, (b) inadequacy of nutritional amino acid substrate and (c) common genetic variations in the UC-NO and the GSH pathways in the pathogenesis of BPD. These factors limit the ability of the anatomically and functionally immature lung to respond to the physiologic and environmental stress of preterm birth. As part of the PROP multi-center study, novel approaches to characterizing lung status with non-invasive respiratory measures prior to NICU discharge will be employed. A composite primary outcome of morbidity that is based on serial parental reports of respiratory symptoms, medications, hospitalizations and dependence on technology during the first year of life has been developed.

Layout table for study information
Study Type : Observational
Actual Enrollment : 253 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Improving Prematurity-Related Respiratory Outcomes at Vanderbilt: The Prematurity and Respiratory Outcomes Program (PROP)
Study Start Date : September 2011
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Respiratory morbidity [ Time Frame: one year corrected age ]
    Need for oxygen, respiratory medications, hospital admissions for respiratory disease or a positive response in at least 1 of 4 morbidity domains during at least 2 separate parental interviews.

Secondary Outcome Measures :
  1. bronchopulmonary dysplasia [ Time Frame: 36 weeks corrected age ]
    need for oxygen at 36 weeks based on a room air challenge

Biospecimen Retention:   Samples With DNA
saliva for DNA, plasma, red blood cells, urine and tracheal aspirates

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 7 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Infants admitted to the Neonatal Intensive Care Unit who are < 29 weeks gestational age

Inclusion Criteria:

  • Infants who are less than or equal to 7 days old;
  • Gestational Age (GA) between 23 weeks and 0/7 days and 28 weeks and 6/7 days

Exclusion Criteria:

  • The infant is not considered to be viable (decision made not to provide life-saving therapies);
  • Congenital heart disease (not including PDA and hemodynamically insignificant VSD or ASD);
  • Structural abnormalities of the upper airway, lungs or chest wall;
  • Other congenital malformations or syndromes that adversely affect life expectancy or cardio-pulmonary development;
  • Family is unlikely to be available for long-term follow-up.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01460576

Layout table for location information
United States, Tennessee
Jackson Madison County General Hospital
Jackson, Tennessee, United States, 38301
Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee, United States, 37232
Sponsors and Collaborators
Vanderbilt University Medical Center
National Heart, Lung, and Blood Institute (NHLBI)
Layout table for investigator information
Principal Investigator: Judy L. Aschner, MD Albert Einstein College of Medicine; Vanderbilt University School of Medicine
Layout table for additonal information
Responsible Party: Paul Moore, Asscoc. Professor, Vanderbilt University Medical Center Identifier: NCT01460576    
Other Study ID Numbers: 110833
1U01HL101456 ( U.S. NIH Grant/Contract )
First Posted: October 27, 2011    Key Record Dates
Last Update Posted: May 5, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Keywords provided by Paul Moore, Vanderbilt University Medical Center:
respiratory disease
bronchopulmonary dysplasia
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Bronchopulmonary Dysplasia
Premature Birth
Respiratory Tract Diseases
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Ventilator-Induced Lung Injury
Lung Injury
Infant, Premature, Diseases
Infant, Newborn, Diseases